Breast Cancer Screening in Latin America: The Challenge to Move from Opportunistic to Organized-Systematic Screening
Main Article Content
Abstract
Background: Breast cancer is the leading cause of death from cancer among women in Latin America. Most Latin American countries started national mammogram screening programs a decade ago. The implementation level and effects of screening programs in Latin America have not been evaluated.
Aim: To evaluate the association between screening programs implementation and breast cancer mortality in selected North American and European countries compared to a group of Latin American countries with national screening programs.
Methods: The study applied an ecological design with secondary data from official national and international sources. Join point regression analysis was conducted to describe the trends in mortality rates in a group of five Latin American countries (Brazil, Chile, Colombia, Costa Rica and Mexico) with five Non-Latin American countries (Canada, Spain, Sweden, United Kingdom and the United States of America). The association between screening and mortality rates was explored using correlation and linear regression. National cancer plans were assessed to describe screening strategies among selected countries.
Results: A significant reduction in standardized breast cancer mortality rates was observed in all Non-Latin American countries with an Average Annual Percent Change (AAPC) of -2.00 (p<.05, 95%CI [-3.33, -0.70]) for the period 2010-2020. In contrast, Latin American countries reported a significant increase in the AAPC of +1.38 (p<.05, 95%CI [0.86,1.76]) in breast cancer mortality rates for the period 2010-2020. For Latin American countries, with screening rates below 50%, there was no correlation between screening and mortality rates for the period 1985-2020 (r = -0.17, p = .78). For non-Latin American countries, with screening rates over 70%, the linear regression model explained significantly 55% of the variance in mortality rates (R2aj =.55, F (5,14) = 5.69, p = .005), with a negative and significant effect of mammogram screening on mortality rates (β = -0.14, p = .01). The National Plans analysis revealed an opportunistic screening model for Latin American countries and an organized-systematic model in Non-Latin American countries.
Conclusion: There is an association between the level of implementation of screening programs and mortality rates from breast cancer. Latin American countries should transform their opportunistic strategy into an organized-systematic model.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
doi: 10.3322/caac.21660
2. World Health Organization, International Agency for Research and Cancer (IARC). Can-cer Today. Gco.iarc.fr. 2020. Accessed on Au-gust 28, 2023. https://gco.iarc.fr/to-day/home.
3. World Health Organization, Panamerican Health Organization (PAHO). Breast Cancer. Paho.org. Accessed September 2, 2023. https://www.paho.org/en/topics/breast-can-cer
4. International Cancer Control Partnership. Na-tional Plans. Iccp-portal.org. Accessed Sep-tember 2, 2023. https://www.iccp-por-tal.org/map.
5. Romero Y, Trapani D, Johnson S, et al. National cancer control plans: a global analysis. Lancet Oncol. 2018t;19(10): e546-e555. doi:10.1016/S1470-2045(18)30681-8.
6. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analy¬sis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016;164(4):244-55.
doi: https://doi.org/10.7326/M15-0969
7. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lan-cet. 2012;380(9855):1778–1786.
doi: https://doi.org/10.1016/S0140-6736(12)61611-0
8. USPSTF Bulletin https://www.uspreventiveserv-icestaskforce.org/files/breast-WASHINGTON, D.C.-May 9, 2023, can-cer/Breast_Cancer_DRS_News_Bulletin.pdf Accessed September 2nd, 2023.
9. Berry DA, Cronin KA, Plevritis SK, et al; Cancer Intervention and Surveillance Modeling Net-work (CISNET) Collaborators. Effect of screen-ing and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-92.
doi: 10.1056/NEJMoa050518
10. Njor S, Nyström L, Moss S, et al; Euroscreen Working Group. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen. 2012;19 Suppl 1:33-41. doi: 10.1258/jms.2012.012080
11. Peisl S, Zimmermann S, Camey B, Betticher D, Bouchardy C. Comparison between opportunis¬tic and organised breast cancer mammography screening in the Swiss canton of Fribourg. BMC Cancer. 2019;19(1):469.
doi: https://doi.org/10.1186/s12885-019-5706-1
12. Sebuødegård S, Botteri E, Hofvind S. Breast Cancer Mortality After Implementation of Or-ganized Population-Based Breast Cancer Screening in Norway. J Natl Cancer Inst. 2020;112(8):839-846. doi: 10.1093/jnci/djz220. Erratum in: J Natl Can-cer Inst. 2020 Oct 1;112(10):1072-1074.
13. Muratov S, Canelo-Aybar C, Tarride JE, et al; ECIBC contributor group. Monitoring and eval-uation of breast cancer screening programmes: selecting candidate performance indicators. BMC Cancer. 2020;20(1):795.
doi: https://doi.org/10.1186/s12885-020-07289-z
14. Guthmuller S, Carrieri V, Wübker A. Effects of organized screening programs on breast can-cer screening, incidence, and mortality in Eu-rope. J Health Econ. 2023; 92:102803. doi: 10.1016/j.jhealeco.2023.102803
15. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer. 2011;117(10):2209-18.
doi: 10.1002/cncr.25679.
16. Gaudette LA, Altmayer CA, Nobrega KM, Lee J. Trends in mammography utilization, 1981 to 1994. Health Rep. 1996;8(3):17-27(Eng); 19-30(Fre). Accessed October 9, 2023. https://pubmed.ncbi.nlm.nih.gov/9085118/.
17. Moss SM, Michel M, Patnick J, Johns L, Blanks R, Chamberlain J. Results from the NHS breast screening programme 1990-1993. J Med Screen. 1995;2(4):186-90. doi: 10.1177/096914139500200403
18. Huang J, Chan PS, Lok V, et al. Global inci-dence, and mortality of breast cancer: a trend analysis. Aging (Albany NY). 2021;13(4):5748-5803. doi: 10.18632/ag-ing.202502.
19. Weiss N. Chapter 3 Diagnostic and screening tests: measuring their role in improving the out-come of illness. Clinical Epidemiology. Second Edition. Oxford Unversity Press, New York, 1996.
20. Walbaum B, Puschel K, Medina L, et al. Screen-detected breast cancer is associated with bet¬ter prognosis and survival compared to self-de¬tected/symptomatic cases in a Chilean cohort of female patients. Breast Cancer Res Treat. 2021;189(2):561-569.
doi: 10.1007/s10549-021-06317-1.
21. Rosa DD, Bines J, Werutsky G, et al. The impact of sociodemographic factors and health insur¬ance coverage in the diagnosis and clinico¬pathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115). Breast Cancer Res Treat. 2020 Oct;183(3):749-757. doi: 10.1007/s10549-020-05831-y
22. Cuoghi IC, da Silva Soares MF, Dos Santos GMC, et al. 10-year opportunistic mammo-graphic screening scenario in Brazil and its im-pact on breast cancer early detection: a nation¬wide population-based study. J Glob Health. 2022; 12:04061.
doi: 10.7189/jogh.12.04061
23. Cazap E. Breast Cancer in Latin America: A Map of the Disease in the Region. Am Soc Clin Oncol Educ Book. 2018; 38:451-456. doi: 10.1200/EDBK_201315
24. Püschel K, Thompson B, Coronado G, et al. 'If I feel something wrong, then I will get a mammo¬gram': understanding barriers and facilitators for mammography screening among Chilean women. Fam Pract. 2010;27(1):85-92. doi: 10.1093/fampra/cmp080
25. Ferreira CS, Rodrigues J, Moreira S, et al. Breast cancer screening adherence rates and barriers of implementation in ethnic, cultural, and religious minorities: A systematic review. Mol Clin Oncol. 2021;15(1):139.
doi: 0.3892/mco.2021.2301
26. Nuche-Berenguer B, Sakellariou D. Socioeco-nomic determinants of cancer screening utilisa-tion in Latin America: A systematic review. PLoS One. 2019;14(11): e0225667.
doi: 10.1371/journal.pone.0225667
27. Wood MF, Vial MC, Martinez-Gutierrez J, et al. Examining barriers for mammography screening compliance within a private hospital and an underserved primary care clinic in San-tiago, Chile. Journal of the American College of Radiology. 2013;10(12):966-71. doi: https://doi.org/10.1016/j.jacr.2013.08.026
28. Akinyemiju T, Ogunsina K, Gupta A, et al. A So¬cio-Ecological Framework for Cancer Preven¬tion in Low and Middle-Income Countries. Front Public Health. 2022; 10:884678. doi: 10.3389/fpubh.2022.884678
29. Primary Health Care for Resilient Health Sys-tems in Latin America, OECD Health Policy Stud¬ies, OECD Publishing,Paris, OECD.org. Pub¬lished December 13, 2022. Accesed 26.10.2023. https://doi.org/10.1787/743e6228-en
30. United Nations Development Program. Human Development Index. Hdr.undp.org. Accesed 26.10.2023. https://hdr.undp.org/data-cen-ter/country-insights#/ranks 3
31. Aguilera X, Delgado I, Icaza G, et al. Under five and infant mortality in Chile (1990-2016): Trends, disparities, and causes of death. PLoS One. 2020;15(9): e0239974. doi: 10.1371/journal.pone.0239974
32. Püschel K, Coronado G, Soto G, et al. Strate-gies for increasing mammography screening in primary care in Chile: results of a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2254-61. doi: 10.1158/1055-9965.EPI-10-0313
33. Puschel K, Rioseco A, Soto G, et al. Long-term Mammography Utilization after an Initial Ran-domized Intervention Period by all Under-served Chilean Women in the Clinics. Cancers (Basel). 2022;14(15):3734.
doi: 10.3390/cancers14153734